A detailed history of Citigroup Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Citigroup Inc holds 331,661 shares of EXAS stock, worth $19.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
331,661
Previous 383,806 13.59%
Holding current value
$19.3 Million
Previous $16.2 Million 39.27%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$42.43 - $70.83 $2.21 Million - $3.69 Million
-52,145 Reduced 13.59%
331,661 $22.6 Million
Q2 2024

Aug 12, 2024

SELL
$41.33 - $74.26 $16 Million - $28.7 Million
-386,578 Reduced 50.18%
383,806 $16.2 Million
Q1 2024

May 10, 2024

BUY
$56.27 - $73.77 $33.2 Million - $43.5 Million
589,281 Added 325.38%
770,384 $53.2 Million
Q4 2023

Feb 09, 2024

BUY
$59.06 - $75.72 $1.14 Million - $1.46 Million
19,253 Added 11.9%
181,103 $13.4 Million
Q3 2023

Nov 09, 2023

BUY
$65.94 - $99.04 $2.55 Million - $3.84 Million
38,726 Added 31.45%
161,850 $11 Million
Q2 2023

Aug 10, 2023

SELL
$62.68 - $95.05 $6.05 Million - $9.17 Million
-96,470 Reduced 43.93%
123,124 $11.6 Million
Q1 2023

May 11, 2023

BUY
$47.19 - $70.77 $1.78 Million - $2.67 Million
37,677 Added 20.71%
219,594 $14.9 Million
Q4 2022

Feb 09, 2023

SELL
$30.35 - $53.15 $3.46 Million - $6.06 Million
-114,074 Reduced 38.54%
181,917 $9.01 Million
Q3 2022

Nov 10, 2022

BUY
$31.97 - $49.37 $2.24 Million - $3.46 Million
69,999 Added 30.97%
295,991 $9.62 Million
Q2 2022

Aug 10, 2022

SELL
$35.61 - $76.23 $183,320 - $392,432
-5,148 Reduced 2.23%
225,992 $8.9 Million
Q1 2022

May 12, 2022

BUY
$57.56 - $82.54 $2.48 Million - $3.56 Million
43,091 Added 22.91%
231,140 $16.2 Million
Q4 2021

Feb 10, 2022

BUY
$72.5 - $100.68 $673,235 - $934,914
9,286 Added 5.19%
188,049 $14.6 Million
Q3 2021

Nov 10, 2021

BUY
$90.24 - $124.05 $16.1 Million - $22.2 Million
178,763 New
178,763 $17.1 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.